Skip to main navigation
Go to  Indivior Pharmaceuticals, Inc. corporate website
  • Overview
  • News & Events
    • Results, Reports & Presentations
    • News Releases
    • Events
  • Stock
    • Stock Quote & Chart
    • Historical Price Lookup
    • Analyst Coverage
  • Shareholder Info
    • Redomiciliation
    • London Delisting
    • Managing Your Shares
    • Shareholder Meetings
    • Investor FAQs
  • Governance
    • Governance Overview
    • Committees
    • Tax Strategy
  • Financials
    • SEC Filings
    • RNS Filings
  • Resources
    • Contact Us
    • Alerts Service
News & Events
  • Results, Reports & Presentations
  • News Releases
  • Events

News Releases

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
December 12, 2016
Indivior R&D Day
December 9, 2016
Indivior PLC Research & Development Day in New York
November 17, 2016
Indivior Applauds United States Surgeon General Report
November 2, 2016
Nine Month Financial Results: Litigation Provision of $220m Booked: Guidance raised
October 3, 2016
Indivior PLC (the “Company”) – Directorate Change
September 27, 2016
Statement Regarding Civil Complaint Filed By State Attorneys General
September 23, 2016
Indivior Notified of Civil Complaint Filed by State Attorneys General
September 20, 2016
INDIVIOR GRANTS $1.2M TO THE MOYER FOUNDATION
September 12, 2016
Morgan Stanley Conference, New York 2016 Presentation PDF being used at Morgan Stanley conference on 9/12/2016
August 17, 2016
RBP-6000 Phase 3 Top Line Results
  • Current page 1
  • Page 2
  • Page 3
  • Next page ›
  • Last page »
Displaying 1 - 10 of 29

Investor Contact

person Jason Thompson
Work Vice President, Investor Relations
drafts InvestorRelations@indivior.com

Subscribe to our Email Alerts

Indivior Pharmaceuticals, Inc. Logo
Indivior Pharmaceuticals, Inc. Logo
© 2026 Indivior Pharmaceuticals, Inc.
This site is intended for US audiences
INDIVIOR is a registered trademark of Indivior UK Limited
Explore
  • Our Company
  • Our Science
  • Our Products
  • Our Impact
Useful Links
  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Cookie Policy
  • Product Query or Adverse Event
Get in touch
  • Contact Us
  • LinkedIn
  • X
  • Our Social Media Community Guidelines
Search Investors